Skip to main content
Erschienen in: Cancer Causes & Control 10/2008

01.12.2008 | Original Paper

Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery

verfasst von: Mary Anne Rossing, Kara L. Cushing-Haugen, Kristine G. Wicklund, Jennifer A. Doherty, Noel S. Weiss

Erschienen in: Cancer Causes & Control | Ausgabe 10/2008

Einloggen, um Zugang zu erhalten

Abstract

Objective

Some forms of ovarian neoplasms may be preventable through the removal of precursor lesions. We assessed the risk associated with a prior diagnosis of, and ovarian surgery following, ovarian cysts and endometriosis, with a focus on characterizing risk among tumor subgroups.

Methods

Information was collected during in-person interviews with 812 women with ovarian cancer diagnosed in western Washington State from 2002 to 2005 and 1,313 population-based controls. Logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs).

Results

The risk of a borderline mucinous ovarian tumor associated with a history of an ovarian cyst was increased (OR=1.7, 95% CI: 1.0–2.8), but did not vary notably according to receipt of subsequent ovarian surgery. While risk of invasive epithelial ovarian cancer was slightly increased among women with a cyst who had no subsequent ovarian surgery, it was reduced when a cyst diagnosis was followed by surgery (OR = 0.6, 95% CI: 0.4–0.9). This reduction in risk was most evident for serous invasive tumors. Women with a history of endometriosis had a threefold increased risk of endometrioid and clear cell invasive tumors, with a lesser risk increase among women who underwent subsequent ovarian surgery.

Conclusions

Our results suggest differences in the relation of ovarian cysts and endometriosis with risk of specific subtypes of ovarian cancer as well as the possibility that ovarian surgery in women with these conditions may lower the risk of invasive disease.
Literatur
1.
Zurück zum Zitat Jordan SJ, Green AC, Whiteman DC, Webb PM (2007) Risk factors for benign, borderline and invasive mucinous ovarian tumors: Epidemiological evidence of a neoplastic continuum? Gynecol Oncol 107:223–230. doi:10.1016/j.ygyno.2007.06.006 Jordan SJ, Green AC, Whiteman DC, Webb PM (2007) Risk factors for benign, borderline and invasive mucinous ovarian tumors: Epidemiological evidence of a neoplastic continuum? Gynecol Oncol 107:223–230. doi:10.​1016/​j.​ygyno.​2007.​06.​006
5.
Zurück zum Zitat Shih IM, Kurman RJ (2004) Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 164:1511–1518PubMed Shih IM, Kurman RJ (2004) Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 164:1511–1518PubMed
13.
Zurück zum Zitat Fritz AG, Percy C, Andrew J et al (2000) International classification of diseases for oncology ICD-O. World Health Organization, Geneva Fritz AG, Percy C, Andrew J et al (2000) International classification of diseases for oncology ICD-O. World Health Organization, Geneva
14.
Zurück zum Zitat Tavassoli FA, Devilee P (2003) World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. IARC Press, Lyon Tavassoli FA, Devilee P (2003) World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. IARC Press, Lyon
15.
Zurück zum Zitat Waksberg J (2000) Random digit dialing sampling for case-control studies. In: Gail MH, Benichou J (eds) Encyclopedia of epidemiologic methods. Wiley, New York, pp 749–753 Waksberg J (2000) Random digit dialing sampling for case-control studies. In: Gail MH, Benichou J (eds) Encyclopedia of epidemiologic methods. Wiley, New York, pp 749–753
16.
Zurück zum Zitat Rossing MA, Cushing-Haugen KL, Wicklund KG, Weiss NS (2008) Cigarette smoking and risk of epithelial ovarian cancer. Cancer Causes Control 19:413–420PubMedCrossRef Rossing MA, Cushing-Haugen KL, Wicklund KG, Weiss NS (2008) Cigarette smoking and risk of epithelial ovarian cancer. Cancer Causes Control 19:413–420PubMedCrossRef
17.
Zurück zum Zitat Weiss NS, Rossing MA (1996) Healthy screenee bias in epidemiologic studies of cancer incidence. Epidemiology 7:319–322PubMed Weiss NS, Rossing MA (1996) Healthy screenee bias in epidemiologic studies of cancer incidence. Epidemiology 7:319–322PubMed
28.
Zurück zum Zitat Erzen M, Rakar S, Klancnik B, Syrjanen K (2001) Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study. Gynecol Oncol 83:100–108. doi:10.1006/gyno.2001.6382 PubMedCrossRef Erzen M, Rakar S, Klancnik B, Syrjanen K (2001) Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study. Gynecol Oncol 83:100–108. doi:10.​1006/​gyno.​2001.​6382 PubMedCrossRef
Metadaten
Titel
Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery
verfasst von
Mary Anne Rossing
Kara L. Cushing-Haugen
Kristine G. Wicklund
Jennifer A. Doherty
Noel S. Weiss
Publikationsdatum
01.12.2008
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 10/2008
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-008-9207-9

Weitere Artikel der Ausgabe 10/2008

Cancer Causes & Control 10/2008 Zur Ausgabe

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.